Last updated on November 2018

Determination of RAS Mutation Status in Liquid Biopsies in Subjects With RAS Wild-type.PERSEIDA Study


Brief description of study

Analysis of freely circulating DNA in liquid biopsies using the BEAMing method

Detailed Study Description

Analysis of freely circulating DNA in liquid biopsies using the BEAMing method is proposed as a technique that may be useful for analysing the RAS mutation status in different types of cancer. However, first it is necessary to evaluate the concordance between the results obtained in tumour samples and liquid biopsies.

Primary objective

To evaluate the RAS mutation status at baseline in liquid biopsies in subjects with RAS wild-type metastatic colorectal cancer.

Secondary objectives

  • To evaluate the appearance of new RAS mutations using liquid biopsies at the moment of disease progression.
  • To evaluate the appearance of new RAS mutations using liquid biopsies prior to radiological documentation of disease progression.

Clinical Study Identifier: NCT02792478

Contact Investigators or Research Sites near you

Start Over

Amgen Call Center

Research Site
Cartagena, Spain
3.12miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.